BioSpace News Archive

Business

SciSparc Makes Another Step Towards Unlocking Potential Value Appoints New Strategy and Business Development VP

SciSparc Ltd. announced that as part of its restructuring plans to unlock value for shareholders, it has appointed a new Vice President of Strategy and Business Development, Mr. Yaki Baranes, to structure business strategies and facilitate identifying new business opportunities.

May 30, 2023
·
3 min read
Biotech Beach

Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the William Blair 43rd Annual Growth Stock Conference, which takes place June 6-8, 2023, in Chicago at the Loews Chicago Hotel.

May 30, 2023
·
3 min read
Genetown

T2 Biosystems Announces Second Largest Sepsis-Driven Instrument Sale in Company History

T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced the second largest sale of sepsis-driven T2Dx® Instruments in Company history.

May 30, 2023
·
4 min read
QuantalX Receives FDA Breakthrough Designation for Diagnosis of Normal Pressure Hydrocephalus and Prediction of Treatment Response

QuantalX, the developer of Delphi-MD, a novel point-of-care neurodiagnostic device, has announced that they have received the prestigious FDA breakthrough designation medical device status for another clinical application, Normal Pressure Hydrocephalus (NPH).

May 30, 2023
·
3 min read
Genetown

First Prospective Clinical Validation of Allarity’s DRP® Companion Diagnostic to be Presented at 2023 ASCO Annual Meeting

Allarity Therapeutics, Inc. announced the results of a prospective Phase 2 clinical study of the Company’s proprietary DRP® technology that will be presented in a poster at the 2023 American Society of Clinical Oncology Annual Meeting on June 3, 2023.

May 30, 2023
·
8 min read
Genetown

Bionomics Announces Upcoming Poster Presentation at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

Bionomics Limited announced it will present data on BNC210 for the treatment of Social Anxiety Disorder at the 2023 American Society of Clinical Psychopharmacology Annual Meeting taking place Tuesday, May 30, 2023, through Friday, June 2, 2023, in Miami Beach, Florida.

May 30, 2023
·
6 min read
Regenative Labs Announces Groundbreaking Study on Application of Wharton’s Jelly for Tissue Defects Involved with Temporomandibular Disorder

Regenative Labs the Pain and Sleep Therapy Center, has sponsored its own independent study approved by the Institutional Review Board (IRB) of the Institute of Cellular and Regenerative Medicine.

May 30, 2023
·
4 min read
Pharm Country

Immunic to Participate in Scientific and Investor Conferences in June 2023

Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced participation in the following scientific and investor conferences in June:

May 30, 2023
·
4 min read
Drug Development

Pfizer Announces Positive Marstacimab Results from Pivotal Phase 3 Hemophilia A and B Trial

Pfizer Inc. announced that the pivotal Phase 3 BASIS clinical trial evaluating marstacimab has met its primary endpoints, having demonstrated statically significant and clinically meaningful effects.

May 30, 2023
·
10 min read
Genetown

Oculis Announces Launch of Proposed Public Offering of Ordinary Shares - May 30, 2023

Oculis Holding AG, a global biopharmaceutical company purposefully driven to save sight and improve eye care, announced the launch of a follow-on public offering of 5,000,000 ordinary shares.

May 30, 2023
·
4 min read